Abdominal Imaging

, Volume 31, Issue 6, pp 644–651

Nodal staging in genitourinary cancers



In patients with genitourinary cancers nodal staging is an integral part of the pretreatment evaluation. The presence of nodal metastatic disease plays an important role in predicting prognosis and treatment planning. Although some nodal groups can be evaluated clinically, most patients undergo various imaging studies for nodal staging. Each modality has its own unique attributes and applications. This article reviews various imaging modalities, namely, contrast enhanced computerized tomography, magnetic resonance imaging (MRI), and positron emission tomography, used for nodal staging in patients with genitourinary cancers and highlights their strengths and weaknesses. Emerging novel techniques such as lymphotropic nanoparticle enhanced MRI are also highlighted.


Nodes Staging Genitourinary cancers 


  1. 1.
    Jemal A, Murray T, Ward E, et al. (2005) Cancer statistics. CA Cancer J Clin 55:10–30PubMedCrossRefGoogle Scholar
  2. 2.
    Gervasi LA, Mata J, Easley JD, et al. (1989) Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142:332–336PubMedGoogle Scholar
  3. 3.
    Borley N, Fabrin K, Sriprasad S, et al. (2003) Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high-risk” prostate cancer compared to MRI or CT. Scand J Urol Nephrol 37:382–386PubMedCrossRefGoogle Scholar
  4. 4.
    Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC (1991) Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the gynecologic oncology group. Cancer 67:2776–2785PubMedCrossRefGoogle Scholar
  5. 5.
    Alvarez RD, Soong SJ, Kinney WK, et al. (1989) Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 35:130–135PubMedCrossRefGoogle Scholar
  6. 6.
    Greer BE, Koh WJ, Stelzer KJ, Goff BA, Comsia N, Tran A (1996) Expanded pelvic radiotherapy fields for treatment of local-regionally advanced carcinoma of the cervix: Outcome and complications. Am J Obstet Gynecol 174:1141–1149; discussion 1149–1150PubMedCrossRefGoogle Scholar
  7. 7.
    Stryker JA, Mortel R (2000) Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol 79:399–405PubMedCrossRefGoogle Scholar
  8. 8.
    Freedman LS, Parkinson MC, Jones WG, et al. (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 2:294–298PubMedCrossRefGoogle Scholar
  9. 9.
    Read G, Stenning SP, Cullen MH, et al. (1992) Medical research council prospective study of surveillance for stage I testicular teratoma. medical research council testicular tumors working party. J Clin Oncol 10:1762–1768PubMedGoogle Scholar
  10. 10.
    Nicolai N, Pizzocaro G (1995) A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 154:1045–1049PubMedCrossRefGoogle Scholar
  11. 11.
    Sedlis A, Homesley H, Bundy BN, et al. (1987) Positive groin lymph nodes in superficial squamous cell vulvar cancer. A gynecologic oncology group study. Am J Obstet Gynecol 156:1159–1164PubMedGoogle Scholar
  12. 12.
    Micali G, Nasca MR, Innocenzi D, Schwartz RA (2004) Invasive penile carcinoma: a review. Dermatol Surg 30:311–320PubMedCrossRefGoogle Scholar
  13. 13.
    Barranger E, Darai E (2004) Lymphatic mapping for gynecologic malignancies. Semin Oncol 31:394–402PubMedCrossRefGoogle Scholar
  14. 14.
    Zincke H, Farrow GM, Myers RP, Benson RC Jr, Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128:498–501PubMedGoogle Scholar
  15. 15.
    Kim JY, Harisinghani MG (2004) MR imaging staging of pelvic lymph nodes. Magn Reson Imaging Clin N Am 12:581–586PubMedCrossRefGoogle Scholar
  16. 16.
    Vinnicombe SJ, Norman AR, Nicolson V, Husband JE (1995) Normal pelvic lymph nodes: Evaluation with CT after bipedal lymphangiography. Radiology 194:349–355PubMedGoogle Scholar
  17. 17.
    Guermazi A, Brice P, Hennequin C, Sarfati E (2003) Lymphography: an old technique retains its usefulness. Radiographics 23:1541–1558, discussion 1559–1560PubMedCrossRefGoogle Scholar
  18. 18.
    Kim SH, Kim SC, Choi BI, Han MC (1994) Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 190:807–811PubMedGoogle Scholar
  19. 19.
    Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR 167:1503–1507PubMedGoogle Scholar
  20. 20.
    Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J (2003) Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91:59–66PubMedCrossRefGoogle Scholar
  21. 21.
    Subak LL, Hricak H, Powell CB, Azizi L, Stern JL (1995) Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86:43–50PubMedCrossRefGoogle Scholar
  22. 22.
    Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C (2000) Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR 175:759–766PubMedGoogle Scholar
  23. 23.
    Pieterman RM, van Putten JW, Meuzelaar JJ, et al. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254–261PubMedCrossRefGoogle Scholar
  24. 24.
    Schoder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274–292PubMedCrossRefGoogle Scholar
  25. 25.
    Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY (2003) Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89:73–76PubMedCrossRefGoogle Scholar
  26. 26.
    Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. (2001) Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 218:776–782PubMedGoogle Scholar
  27. 27.
    Oyama N, Akino H, Kanamaru H, et al. (2002) 11C-Acetate PET imaging of prostate cancer. J Nucl Med 43:181–186PubMedGoogle Scholar
  28. 28.
    Tiguert R, Gheiler EL, Tefilli MV, et al. (1999) Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology 53:367–371PubMedCrossRefGoogle Scholar
  29. 29.
    Heller PB, Maletano JH, Bundy BN, Barnhill DR, Okagaki T (1990) Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis––a gynecologic oncology group study. Gynecol Oncol 38:425–430PubMedCrossRefGoogle Scholar
  30. 30.
    Yu KK, Hricak H, Subak LL, Zaloudek CJ, Powell CB (1998) Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. AJR 171:707–711PubMedGoogle Scholar
  31. 31.
    Bellin MF, Lebleu L, Meric JB (2003) Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 28:155–163PubMedCrossRefGoogle Scholar
  32. 32.
    Bellin MF, Roy C, Kinkel K, et al. (1998) Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles––initial clinical experience. Radiology 207:799–808PubMedGoogle Scholar
  33. 33.
    Harisinghani MG, Barentsz J, Hahn PF, et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRefGoogle Scholar
  34. 34.
    Harisinghani MG, Barentsz JO, Hahn PF, et al. (2002) MR lymphangiography for detection of minimal nodal disease in patients with prostate cancer. Acad Radiol 9 (Suppl 2):S312–S313PubMedCrossRefGoogle Scholar
  35. 35.
    Harisinghani MG, Saini S, Hahn PF, Weissleder R, Mueller PR (1998) MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (combidex). Acad Radiol 5 (Suppl 1):S167–S169, discussion S183–S184PubMedCrossRefGoogle Scholar
  36. 36.
    Rockall AG, Sohaib SA, Harisinghani MG, et al. (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23:2813–2821PubMedCrossRefGoogle Scholar
  37. 37.
    Anzai Y, Piccoli CW, Outwater EK, et al. (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228:777–788PubMedGoogle Scholar
  38. 38.
    Harisinghani MG, Dixon WT, Saksena MA, et al. (2004) MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24:867–878PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • M. A. Saksena
    • 1
  • J. Y. Kim
    • 1
  • M. G. Harisinghani
    • 1
  1. 1.Department of RadiologyMassachusetts General HospitalBostonUSA

Personalised recommendations